{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:34:45Z","timestamp":1763346885478,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009429","name":"Israel National Road Safety Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F30AG067643"],"award-info":[{"award-number":["F30AG067643"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM73009"],"award-info":[{"award-number":["T32 GM73009"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jagp.2021.07.017","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T19:15:14Z","timestamp":1627758914000},"page":"329-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Invited Perspective on the \u201cLong-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-label Extension of a Phase 3 Randomized Controlled Trial\u201d"],"prefix":"10.1016","volume":"30","author":[{"given":"Jared T.","family":"Hinkle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Pontone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2021.07.017_bib0001","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.parkreldis.2010.06.004","article-title":"Levodopa response in dementia with Lewy bodies: a 1-year follow-up study","volume":"16","author":"Lucetti","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2021.07.017_bib0002","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","article-title":"The role of levodopa in the management of dementia with Lewy bodies","volume":"76","author":"Molloy","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jagp.2021.07.017_bib0003","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jagp.2021.07.002","article-title":"Long-term efficacy and safety of zonisamide for treatment of parkinsonism in patients with dementia with lewy bodies: an open-label extension of a phase 3 randomized controlled trial","volume":"30","author":"Odawara","year":"2022","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2021.07.017_bib0004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.parkreldis.2019.12.005","article-title":"Effect of zonisamide on parkinsonism in patients with dementia with Lewy bodies: a phase 3 randomized clinical trial","volume":"76","author":"Murata","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jagp.2021.07.017_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ncn3.12026","article-title":"Randomized placebo-controlled trial of zonisamide in patients with Parkinson's disease","volume":"4","author":"Murata","year":"2016","journal-title":"Neurol Clin Neurosci"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121004127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121004127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:33:37Z","timestamp":1761021217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748121004127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1064748121004127"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2021.07.017","relation":{},"ISSN":["1064-7481"],"issn-type":[{"type":"print","value":"1064-7481"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invited Perspective on the \u201cLong-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-label Extension of a Phase 3 Randomized Controlled Trial\u201d","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2021.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}